(LSE: PEYS/PEY)
Partners Group Private Equity
Limited
NAV increases by 0.5% in
September
· NAV
increased by 0.5% to EUR 14.24 per share; total net assets at EUR
984.62 million
· Positive
value creation (0.9%) partially offset by adverse currency
movements (-0.3%)
·
KinderCare, the fifth largest portfolio company in PGPE Ltd, was
the largest contributor to the NAV increase following its IPO
pricing
· PGPE Ltd
invested EUR 6.7 million and received distributions of EUR 6.3
million
In September, PGPE Ltd invested EUR 6.7 million, of
which EUR 5.5 million was in FairJourney Biologics, a leading
European antibody discovery Contract Research Organization (CRO)
based in Porto, Portugal. Founded in 2012, FairJourney provides
services for the discovery, engineering, production, and
characterization of antibodies. FairJourney has worked with over
250 clients across the globe to develop more than 4,000 unique
screening libraries for identifying antibodies. The company's
partnerships with its customers have yielded 14 therapies that are
currently in active clinical development to treat unmet patient
needs across oncology, immunology, and cardiovascular disease.
FairJourney is set to benefit from structural market tailwinds,
including increased R&D spend, outsourcing trends, and a
favorable regulatory landscape. Partners Group will work with
management on a value creation plan for FairJourney that will
expand its technology and capabilities through organic and
inorganic investment to unlock faster, more effective drug
development for its partners.
PGPE Ltd received distributions totaling EUR 6.3
million, with EUR 6.0 million coming from the sale of a portion of
its stake in Galderma, a pure-play dermatology category leader. The
shares were sold to L'Oréal, via an off-market block
trade that saw the French beauty and cosmetics group invest for a
10% stake in Galderma. The two companies have also agreed on a
scientific partnership to develop advanced, future-proof
technologies with direct applications in the field of
dermatology.
Further information is available in the monthly
report, which can be accessed via:
https://www.partnersgroupprivateequitylimited.com/en/investor-relations/financial-reports/
Ends.
About Partners Group
Private Equity Limited
PGPE Ltd (formerly Princess Private Equity Holding
Limited) is an investment holding company founded in 1999 and
domiciled in Guernsey. It invests in private equity direct
investments. PGPE Ltd is managed in its investment activities by
Partners Group, a global private markets investment management firm
with USD 149 billion in investment programs under management in
private markets, of which USD 76 billion is in private equity. PGPE
Ltd aims to provide shareholders with long-term capital growth and
an attractive dividend yield. PGPE Ltd is traded on the Main Market
of the London Stock Exchange (ticker: PEY for the Euro Quote; PEYS
for the Sterling Quote).
Contacts
Partners Group Private Equity Limited:
pgpe-ltd@partnersgroup.com
www.partnersgroupprivateequitylimited.com
|
Investor relations contact:
Andreea Mateescu
Phone: +41 41 784 66 73
E-mail: andreea.mateescu@partnersgroup.com
|
Media relations contact:
Jenny Blinch
Phone: +41 41 784 65 26
E-mail:
jenny.blinch@partnersgroup.com
|
Registered Number:
35241 LEI: 54930038LU8RDPFFVJ57
Notes:
1. Note that
references in this announcement to Partners
Group Private Equity Limited have been
abbreviated to "PGPE Ltd" or "Company". References to Partners
Group AG have been abbreviated to "Partners Group" or "Investment
Manager".
2. This
document does not constitute an offer to sell or a solicitation of
an offer to buy or subscribe for any securities and neither is it
intended to be an investment advertisement or sales instrument
of Partners Group Private Equity
Limited. The distribution of this document
may be restricted by law in certain jurisdictions. Persons into
whose possession this document comes must inform themselves about
and observe any such restrictions on the distribution of this
document. In particular, this document and the information
contained therein is not for distribution or publication, neither
directly nor indirectly, in or into the United States of America,
Canada, Australia or Japan.
3.
This document may have been prepared using
financial information contained in the books and records of the
product described herein as of the reporting date. This information
is believed to be accurate but has not been audited by any third
party. This document may describe past performance, which may not
be indicative of future results. No liability is accepted for any
actions taken on the basis of the information provided in this
document. Neither the contents of PGPE Ltd' website nor the
contents of any website accessible from hyperlinks on PGPE Ltd'
website (or any other website) is incorporated into, or forms part
of, this announcement.
